Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten

Clinical and Experimental Immunology

Volumn 169, Issue 2, 2012, Pages 129-136

  Camarca, A ^a,b   Radano, G ^a   Di Mase, R ^b   Terrone, G ^b   Maurano, F ^a   Auricchio, S ^b   Troncone, R ^b   Greco, L ^b   Gianfrani, C ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

ELISPOT; In vivo challenge; Interferon ; Peripheral blood; Wheat gluten

Indexed keywords

BETA7 INTEGRIN; GAMMA INTERFERON; GLIADIN; GLUTEN; HLA DQ ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; ASSAY; BREAD; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUTEN FREE DIET; HUMAN; IN VIVO STUDY; INGESTION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; REMISSION; REPRODUCIBILITY; WHEAT;

ADOLESCENT; ADULT; ANTIGENS, PLANT; CELIAC DISEASE; EPITOPES; FEMALE; GLIADIN; GLUTENS; HLA-DQ ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PEPTIDES; TIME FACTORS; TRITICUM; YOUNG ADULT;

EID: 84863564663     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04597.x     Document Type: Article

References (26)

1. Jabri B, Sollid LM. Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol 2006; 3:516-25.
2. Camarca A, Anderson RP, Mamone G etal. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J Immunol 2009; 182:4158-66.
3. Arentz-Hansen H, McAdam SN, Molberg Ø etal. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002; 123:803-09.
4. Anderson RP, Degano P, Godkin AJ etal. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000; 6:337-42.
5. Anderson RP, van Heel DA, Tye-Din JA etal. T cells in peripheral blood after gluten challenge in coeliac disease. Gut 2005; 54:1217-23.
6. Tye-Din JA, Stewart JA, Dromey JA etal. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med 2010; 2:41ra51.
7. Ráki M, Fallang LE, Brottveit M etal. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc Natl Acad Sci USA 2007; 104:2831-36.
8. Bodd M, Ráki M, Tollefsen S etal. HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol 2010; 3:594-01.
9. Ellis HJ, Ciclitira PJ. In vivo gluten challenge in celiac disease. Can J Gastroenterol 2001; 15:243-47.
10. Dewar DH, Amato M, Ellis HJ etal. The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease. Eur J Gastroenterol Hepatol 2006; 18:483-91.
11. Fraser JS, Engel W, Ellis HJ etal. Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut 2003; 52:1698-02.
12. Ciacci C, Maiuri L, Caporaso N etal. Celiac disease: in vitro and in vivo safety and palatability of wheat-free sorghum food products. Clin Nutr 2007; 26:799-05.
13. Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB. The safety, tolerance, pharmacodynamic effects of single doses of AT-1001 in celiac disease subjects: a proof of concept study. Aliment Pharmacol Ther 2007; 26:757-66.
14. Carroccio A, Iacono G, Montalto G etal. Immunologic and absorptive tests in celiac disease: can they replace intestinal biopsies? Scand J Gastroenterol 1993; 28:673-76.
15. Tveito K, Brunborg C, Bratlie J etal. Intestinal malabsorption of d-xylose: comparison of test modalities in patients with celiac disease. Scand J Gastroenterol 2010; 45:1289-94.
16. Brottveit M, Ráki M, Bergseng E etal. Assessing possible celiac disease by an HLA-DQ2-gliadin tetramer test. Am J Gastroenterol 2011; 106:1318-24.
17. Troncone R, Ivarsson A, Szajewska H etal. Review article: future research on coeliac disease-a position report from the European multistakeholder platform on celiac disease (CDEUSSA). Aliment Pharmacol Ther 2008; 27:1030-43.
18. Tosco A, Salvati V, Auricchio R etal. Natural history of potential celiac disease in children. Clin Gastroenterol Hepatol 2011; 9:320-25.
19. Report of the Working Group of European Society of Paediatric Gastroenterology and Nutrition. Revised criteria for the diagnosis of coeliac disease. Arch Dis Child 1990; 65:909-11.
20. Wieser H, Antes S, Seilmeier W. Quantitative determination of gluten protein types in wheat flour by reversed-phase high-performance liquid chromatography. Cereal Chem 1998; 75:664-50.
21. Gianfrani C, Siciliano RA, Facchiano AM etal. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 2007; 133:780-89.
22. Gianfrani C, Troncone R, Mugione P etal. Coeliac disease association with CD8+ T cell responses: identification of a novel gliadin-derived HLA-A2 restricted epitope. J Immunol 2003; 170:2719-26.
23. Tye-Din JA, Anderson RP, Ffrench RA etal. The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clin Immunol 2010; 134:289-95.
24. Gjertsen HA, Sollid LM, Ek J, Thorsby E, Lundin KE. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol 1994; 39:567-74.
25. Ben-Horin S, Green PH, Bank I, Chess L, Goldstein I. Characterizing the circulating, gliadin-specific CD4+ memory T cells in patients with celiac disease: linkage between memory function, gut homing and Th1 polarization. J Leukoc Biol 2006; 79:676-85.
26. Jensen K, Sollid LM, Scott H etal. Gliadin-specific T cell responses in peripheral blood of healthy individuals involve T cells restricted by the coeliac disease associated DQ2 heterodimer. Scand J Immunol 1995; 42:166-70.